The Advisory Group (AG) is part of the PIP Framework's "Governance and Review" structure. Its functions include monitoring implementation of the PIP Framework, and providing evidence-based reporting, assessment and recommendations regarding its functioning. Among its many areas of work, the AG interacts with industry and other stakeholders and provides advice to the Director-General on the use of the Partnership Contribution. The AG also provides to the Director-General an annual report on its evaluation of implementation of the PIP Framework.
Notice to Stakeholders
All stakeholders are reminded that contact with the Advisory Group or its members should take place only through established channels during Advisory Group sessions. Stakeholders are kindly asked to respect this principle that ensures the integrity of the Advisory Group, its membership and its processes and proceedings. Any Advisory Group member contacted directly by any stakeholder should remind the stakeholder of this notice.
Members of the PIP Advisory Group
According to Annex 3 of the PIP Framework, the Advisory Group will be comprised of 18 members drawn from three Member States in each WHO Region. The members will have a skill mix of internationally recognized policy makers, public health experts and technical experts in the field of influenza. In the exercise of their functions the Members shall act as international experts serving WHO exclusively. They will serve three year terms.
The biographies of current, as well as previous, AG members can be found here:
Advisory Group Special Session, 13-14 October 2015
Advisory Group Special Session Report to the Director-General
Revised Draft Provisional Agenda
Briefing Note for the PIP Advisory Group Special Session
Germany’s statement on substantive issues and concerns regarding the PIP Framework and its implementation